Arkolith/Insider Trading/WHWK/Form 4

Castelein Caley

DirectorWhitehawk Therapeutics, Inc. (WHWK) · full profile →Form 4 · filed May 18, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 14, 2026Grant(A)255K$3.92$1000K275K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 14, 2026Grant(A)2.1M$8124996.24$16.8T2.1M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001355758-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML